Amanote Research

Amanote Research

    RegisterSign In

Belimumab

Drugs in R and D - United Kingdom
doi 10.2165/11538300-000000000-00000
Full Text
Open PDF
Abstract

Available in full text

Categories
Pharmacology
Date

May 1, 2010

Authors

Unknown

Publisher

Springer Science and Business Media LLC


Related search

Belimumab in Kidney Transplantation

The Lancet
Medicine
2019English

Belimumab in Kidney Transplantation – Authors' Reply

The Lancet
Medicine
2019English

Belimumab in Systemic Lupus Erythematosus

RMD Open
RheumatologyAllergyImmunology
2015English

Belimumab in Systemic Lupus Erythematosus: An Update for Clinicians

Therapeutic Advances in Chronic Disease
Medicine
2011English

Refractory Autoimmune Hemolytic Anemia in a Pediatric SLE Patient Treated With Belimumab

Annals of Paediatric Rheumatology
2013English

Experience of Long-Term Belimumab Use in Patients With Systemic Lupus Erythematosus (A Case Report)

Modern Rheumatology Journal
2013English

Pharmacogenetic Analysis of Belimumab Fails to Identify Robust Genetic Predictors of Efficacy in Lupus

Pharmacogenetics and Genomics
Molecular MedicineGeneticsMolecular Biology
2019English

SAT0241 Early Response to Belimumab in Sle-Related Joint Involvement Evaluated by Ultrasonographic Assessment

2017English

Estimating the Cost-Effectiveness of Belimumab Versus Standard Care for Sle Patients in Hong Kong

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy